NTRK1 and thyroid gland papillary carcinoma: The study evaluated multiple RNA‐based NGS panels for the identification of NTRK fusions, including TPM3‐NTRK1, in various cancer samples, including lung adenocarcinoma and papillary thyroid carcinoma (PTC).